Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Qsymia combines a weight-loss stimulant with an epilepsy drug, carrying risks of abuse, heightened heart rate, and possible birth defects
In contrast, two independent embryos harboring biallelic Trim37 mutations displayed severe PGC loss, fulfilling our predefined screening criteria for a positive hit and identifying Trim37 as a positive candidate gene in this screen (Fig
"Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes"
Some individuals, such as those with heart failure, kidney disease, or certain electrolyte imbalances, may face increased risks with IV therapy
Trans-activation of eotaxin-1 by Brg1 contributes to liver regeneration
